Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Roedler, S; Czerny, M; Neuhauser, J; Zimpfer, D; Gottardi, R; Dunkler, D; Wolner, E; Grimm, M.
Mechanical aortic valve prostheses in the small aortic root: Top Hat versus standard CarboMedics aortic valve.
Ann Thorac Surg. 2008; 86(1):64-70 Doi: 10.1016/j.athoracsur.2008.01.085
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Zimpfer Daniel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: The purpose of this study was to evaluate outcome in patients with a small aortic root receiving either a standard CarboMedics mechanical aortic valve or a Top Hat CarboMedics valve (CarboMedics, Austin, TX), specifically designed for the small aortic root. METHODS: Between 1986 and 2006, 316 consecutive patients underwent 19- or 21-mm mechanical aortic valve replacement, receiving either a CarboMedics Top Hat bileaflet valve (n = 56; mean age, 66 +/- 14 years) or a standard CarboMedics aortic valve replacement (n = 260; mean age, 60 +/- 13 years) at our institution based on institutional indications for the choice of type of valve prostheses. Median follow-up time was 83.5 months. We studied survival, valve-related and non-valve-related events, and hemodynamic performance by serial echocardiographic follow-up studies. RESULTS: In-hospital mortality was 8.9% in the Top Hat group and 10.0% in the standard group (p = 0.354). Five- and ten-year survival in patients in the Top Hat group was 83% and 67%, respectively. Five- and ten-year survival in the standard group was 73% and 59%, respectively (log-rank = 0.331). There were no differences in regard to valve-related and non-valve-related events. Cox regression analysis revealed age (hazard ratio, 1.045; 95% confidence interval, 1.026 to 1.066), previous cardiac surgery (hazard ratio, 1.812; 95% confidence interval, 1.101 to 2.982), additional procedures at the time of valve replacement (hazard ratio, 2.604; 95% confidence interval, 1.651 to 4.108), New York Heart Association class IV (hazard ratio, 3.645; 95% confidence interval, 1.214 to 10.945), and severely impaired left ventricular ejection fraction (hazard ratio, 2.253; 95% confidence interval, 1.289 to 3.941) to be independent predictors of survival. CONCLUSIONS: Mechanical aortic valve replacement in the small aortic root is associated with substantial perioperative mortality, in particular in the subset of patients requiring additional cardiac surgical procedures. Nevertheless, long-term outcome is satisfying. Because the type of prosthesis does not predict outcome in the multivariate Cox model, we conclude that use of the smaller Top Hat prosthesis can be recommended for the challenging cohort of patients with a small aortic root.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent - administration & dosage
Adult - administration & dosage
Aged - administration & dosage
Aged, 80 and over - administration & dosage
Aortic Valve Stenosis - diagnostic imaging, mortality, therapy
Bioprosthesis - administration & dosage
Cohort Studies - administration & dosage
Echocardiography, Doppler - administration & dosage
Female - administration & dosage
Follow-Up Studies - administration & dosage
Heart Valve Prosthesis - administration & dosage
Heart Valve Prosthesis Implantation - adverse effects, methods
Hospital Mortality - trends
Humans - administration & dosage
Kaplan-Meier Estimate - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Postoperative Complications - administration & dosage
Proportional Hazards Models - administration & dosage
Prosthesis Design - administration & dosage
Prosthesis Failure - administration & dosage
Retrospective Studies - administration & dosage
Risk Assessment - administration & dosage
Statistics, Nonparametric - administration & dosage
Survival Rate - administration & dosage
Time Factors - administration & dosage
Treatment Outcome - administration & dosage

© Med Uni GrazImprint